Sunday, August 2, 2015 Last update: 1:03 PM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Vascular Pathways Names Scott Pease as Vice President of Regulatory Affairs and Quality Assurance

Companies mentioned in this article: Vascular Pathways, Inc.

NAPLES, FL--(Marketwired - June 19, 2014) - Vascular Pathways, Inc., a privately held medical device manufacturer with innovative wire-guided technology for peripheral intravascular access, today announced the company has appointed Scott Pease as Vice President of Regulatory Affairs and Quality Assurance.

"We are very excited to have Scott Pease join Vascular Pathways to provide regulatory and quality leadership for the AccuCath™ IV Catheter System," said Bill Bold, Vascular Pathways' President and CEO. "We look forward to his guidance in focusing on opportunities to improve outcomes for patients and healthcare providers globally."

"I feel thrilled and privileged," commented Pease, "to be a part of this dynamic team that is transforming how the clinical world looks at the PIV catheter segment. The AccuCath™ device is truly a game-changer, and I look forward to being a part of its worldwide success."

Pease has over 20 years of experience in the global medical device industry and brings a wealth of global regulatory and quality system expertise to the executive team. Most recently he was a Senior Leader, Global Regulatory Affairs at Kimberly-Clark Corporation, where he supported the commercialization of their retail (OTC) medical devices. During his 20+ years in the global medical device industry, he has held multiple leadership positions in regulatory affairs (RA) and quality assurance (QA), including serving as a Senior RA Professional at Bard Medical, C. R. Bard, Inc., RA Manager at B. Braun Medical Inc., Director of QA/RA at Camtronics Medical Systems, Manager of QA/RA at Mortara Instrument, and Director of RA/QA at Biochem International.  

About Vascular Pathways, Inc.

Founded in 2005, by Amir Belson, M.D., Vascular Pathways, privately held by CHL Medical Partners, Ascension Health Ventures, and MVM Life Sciences, is a medical device company commercializing the AccuCath™ IV Catheter System, an FDA approved, guidewire catheter system enabling rapid, safe, and successful IV insertion. For further information about Vascular Pathways or the AccuCath™ IV catheter line, please visit http://www.vascularpathways.com or call 239-254-0391.


Contact:

Vascular Pathways
Email contact 
239-254-0391